Noninvasive fatty liver markers predict liver disease mortality in the U.S. population.
about
Emerging new standard for non-invasive assessment of liver disease mortality in non-alcoholic fatty liver disease.Characterization of transcriptional modules related to fibrosing-NAFLD progression.Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States.Fimasartan Ameliorates Nonalcoholic Fatty Liver Disease through PPARδ Regulation in Hyperlipidemic and Hypertensive Conditions.Binge drinking and the risk of liver events: A population-based cohort study.Liver fibrosis scores predict liver disease mortality in the United States population.Prediction of Disseminated Intravascular Coagulation by Liver Function Tests in Patients with Japanese Spotted Fever.The natural history of nonalcoholic fatty liver disease: mortality rates and liver enzymes.Among Patients with Nonalcoholic Fatty Liver Disease, Modest Alcohol Use is Associated with Less Improvement in Histologic Steatosis and Steatohepatitis.Diagnostic Accuracy of Platelet Count and Platelet Indices in Noninvasive Assessment of Fibrosis in Nonalcoholic Fatty Liver Disease Patients.Quantitative assessment of liver fibrosis reveals a nonlinear association with fibrosis stage in nonalcoholic fatty liver disease.Implication of liver enzymes on incident cardiovascular diseases and mortality: A nationwide population-based cohort study.A Population-Based Cross-Sectional Study of the Association between Liver Enzymes and Lipid Levels.Non-alcoholic fatty liver diseasePutting non-alcoholic fatty liver disease on the radar for primary care physicians: how well are we doing?
P2860
Q33621516-328D324B-85FA-4718-AABB-44D49C4468B6Q33881352-E060A2E7-2E58-4440-99DA-F9B94CAAF804Q36324068-5071250A-A915-4276-98E2-22EBA63329C0Q37721436-C11168B5-C6B9-4D79-91EE-5B9009A5BE35Q38919058-0A1ED338-A6C6-45C7-A1EB-1A5F1F523580Q38962539-54637520-EA99-4C0F-9E0E-CE3057E3360CQ41922144-052FA888-B5A0-4004-959C-0207DB15BA2BQ42356679-A4ADCC89-5480-4593-990B-599C2E6EAAFBQ47548393-31D76B8F-8554-4872-AE14-D90FD162B305Q49724278-2AA9E175-5599-4DC7-BB2D-CBFEFEE74367Q52699058-7CE1F802-3A9F-46F3-BD9D-A7D5963695F0Q53081272-8867F1BC-A7CE-4188-A784-F2CBAE98F853Q55415785-56817A2C-19F3-4CCD-8869-B1F9431F9B5DQ56003593-702C24DC-FBCA-45C4-958B-E3A6A7931C0BQ58709149-DEF896B4-E1F8-4227-8C7A-833FEE05D873
P2860
Noninvasive fatty liver markers predict liver disease mortality in the U.S. population.
description
2015 nî lūn-bûn
@nan
2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Noninvasive fatty liver markers predict liver disease mortality in the U.S. population.
@ast
Noninvasive fatty liver markers predict liver disease mortality in the U.S. population.
@en
type
label
Noninvasive fatty liver markers predict liver disease mortality in the U.S. population.
@ast
Noninvasive fatty liver markers predict liver disease mortality in the U.S. population.
@en
prefLabel
Noninvasive fatty liver markers predict liver disease mortality in the U.S. population.
@ast
Noninvasive fatty liver markers predict liver disease mortality in the U.S. population.
@en
P2860
P356
P1433
P1476
Noninvasive fatty liver markers predict liver disease mortality in the U.S. population.
@en
P2093
Aynur Unalp-Arida
Constance E Ruhl
P2860
P304
P356
10.1002/HEP.28390
P407
P577
2015-12-10T00:00:00Z